Treatment of Upper Eyelid Retraction: Internal Approach

2008 ◽  
pp. 145-151
Author(s):  
Allen M. Putterman
Keyword(s):  
Eyelid Retraction ◽  
Upper Eyelid ◽  
Upper Eyelid Retraction

Antibodies against Calsequestrin and Type XIII Collagen are Good Markers for Chronic Upper Eyelid Retraction

2007 ◽  
Vol 15 (2) ◽  
pp. 81-88 ◽  
Author(s):  
Bamini Gopinath ◽  
Cherie-Lee Adams ◽  
Reilly Musselman ◽  
Junichi Tani ◽  
Jack R. Wall
Keyword(s):  
Eyelid Retraction ◽  
Upper Eyelid ◽  
Type Xiii Collagen ◽  
Upper Eyelid Retraction

Supranuclear Ophthalmoplegia

2019 ◽  
pp. 137-140
Author(s):  
Matthew J. Thurtell ◽  
Robert L. Tomsak
Keyword(s):  
Differential Diagnosis ◽  
Progressive Supranuclear Palsy ◽  
Clinical Features ◽  
Practical Approach ◽  
Blink Rate ◽  
Ocular Motor ◽  
Eyelid Retraction ◽  
Upper Eyelid ◽  
Convergence Insufficiency ◽  
Upper Eyelid Retraction

Supranuclear ophthalmoplegia results from an interruption of the saccadic, pursuit, optokinetic, or vergence inputs to the ocular motor nuclei. In this chapter, we begin by reviewing potential causes for difficulty reading. We next review the neuro-ophthalmic and neurologic features of progressive supranuclear palsy, which can include a vertical supranuclear ophthalmoplegia, convergence insufficiency, square-wave jerks, upper-eyelid retraction, reduced blink rate, apraxia of eyelid opening, and blepharospasm. We then discuss the differential diagnosis of progressive supranuclear palsy and point out clinical features that help to differentiate these conditions. Lastly, we present a practical approach to the management of the visual symptoms commonly caused by progressive supranuclear palsy.

Course of upper eyelid retraction in thyroid eye disease

2019 ◽  
Vol 104 (2) ◽  
pp. 254-259
Author(s):  
Dong Cheol Lee ◽  
Stephanie M Young ◽  
Yoon-Duck Kim ◽  
Kyung In Woo
Keyword(s):  
Positive Family History ◽  
Thyroid Stimulating Hormone ◽  
Thyroid Eye Disease ◽  
Eye Disease ◽  
Clinical Activity ◽  
Eyelid Retraction ◽  
Tertiary Institution ◽  
Upper Eyelid ◽  
Upper Eyelid Retraction ◽  
History Of

AimsTo evaluate the natural course of upper eyelid retraction (UER) in patients with thyroid eye disease (TED) and factors affecting its course.MethodsRetrospective non-interventional cohort study in a single tertiary institution from March 2006 to March 2015 on patients with TED with (1) unilateral or bilateral UER within 6 months from initial presentation, and (2) no prior interventions nor surgical treatment for their UER. Main outcomes and measures were mean margin reflex distance 1 (MRD1) and factors associated with UER improvement.ResultsThere were a total of 61 patients and 81 eyes (41 unilateral and 20 bilateral UER). Mean age was 42.3±15.1 years. Mean MRD1 decreased from 6.1 mm at presentation to 4.8 mm at 12 months, and 4.4 mm at 24 months. The proportion of eyes with normalisation of lid height increased from 0% at presentation to 22.2% at 6 months, 37.0% at 12 months and 49.4% at 24 months. Mean time to normalisation of MRD1 was 18.0±12.4 months. A positive family history of TED was found to be associated with a 6.2 times lower likelihood of normalisation. Change in exophthalmometry, clinical activity score and thyroid-stimulating immunoglobulin were significantly correlated to change in MRD1 (p<0.05). There was no correlation between change in MRD1 and thyroid-stimulating hormone receptor antibodies.ConclusionAn improved knowledge of the natural history of UER in TED will allow us to better decide and evaluate the optimal management for such patients.

Sign in / Sign up

Export Citation Format

Share Document